Skip Navigation LinksHome > June 2013 - Volume 20 - Issue 6 > Contributor Index

June 2013 - Volume 20 - Issue 6 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 5 Next
Author Name Article
Adler, Nancy E. PhD

Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
and the Ospemifene Study Group

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Free Access
Editorial
OPEN Access
Abstract
PDF
+ Favorites
Request Permissions
Andrade, Juan E. PhD

Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bachmann, Gloria A. MD

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Free Access
Editorial
OPEN Access
Abstract
PDF
+ Favorites
Request Permissions
Bell, Robin J. MBBS, PhD

Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Benzineb, Sarah MD

Comparative study of the quality of life associated with menopause in Tunisia and France

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
Bleil, Maria E. PhD

Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
Branscum, Adam J. PhD

Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bromberger, Joyce T. PhD

Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
Carbone, Laura D. MD, MS

Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
Cedars, Marcelle I. MD

Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
Chang, Je-Ken MD

(−)-Epigallocatechin-3-gallate improves bone microarchitecture in ovariectomized rats

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chang, Wen-Chi MS

In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Chia-Hsin MD, PhD

(−)-Epigallocatechin-3-gallate improves bone microarchitecture in ovariectomized rats

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Chung-Hwan MD

(−)-Epigallocatechin-3-gallate improves bone microarchitecture in ovariectomized rats

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Hui-Ting PhD

(−)-Epigallocatechin-3-gallate improves bone microarchitecture in ovariectomized rats

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Jiun-Liang MD

In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Wei-Shone MD, PhD

In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chiu, Jen-Hwey MD, PhD

In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chlebowski, Rowan T. MD, PhD

Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial

Purchase Access
Editorial
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 5 Next